Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Laboratoires Filorga is a prominent French skincare brand that bridges the gap between medical aesthetics and consumer cosmetics. Founded in 1978 by Dr. Michel Tordjman, the company initially focused on injectable poly-revitalizing solutions for professional use before launching its "Medi-Cosmetique" line for the general public. The brand's signature technology, NCEF (New Cellular Encapsulated Factors), incorporates the same active ingredients used in medical injections into topical creams via specialized encapsulation. In 2019, the company was acquired by Colgate-Palmolive for approximately $1.69 billion to serve as a cornerstone of its professional skincare portfolio. Today, Filorga is a global leader in anti-aging skincare, marketed in over 70 countries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laboratoires Filorga.